广誉远（600771）8月12日主力资金净流出2852.60万元

Group 1 - The core viewpoint of the news is that Guangyuyuan (600771) has shown a decline in stock price and significant net outflow of funds, despite reporting strong revenue and profit growth in its latest quarterly results [1][3] - As of August 12, 2025, Guangyuyuan's stock closed at 21.2 yuan, down 1.03%, with a trading volume of 77,500 hands and a transaction amount of 165 million yuan [1] - The company experienced a net outflow of 28.52 million yuan in main funds, accounting for 17.25% of the transaction amount, with large orders contributing to the majority of the outflow [1] Group 2 - In the latest quarterly report, Guangyuyuan reported total operating revenue of 417 million yuan, a year-on-year increase of 21.48%, and a net profit attributable to shareholders of 63.58 million yuan, up 53.94% [1] - The company's liquidity ratios are strong, with a current ratio of 2.158 and a quick ratio of 1.134, while the debt-to-asset ratio stands at 31.11% [1] - Guangyuyuan, established in 1996, is primarily engaged in the pharmaceutical manufacturing industry and has a registered capital of 4.89 billion yuan [1][2]